Join to view full profile
9500 Euclid Ave# NA23Cleveland, OH 44195
Phone+1 216-444-2200
Dr. Kundrick is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Avery Kundrick, MD is a neurologist specializing in the diagnosis and treatment of movement disorders, including Parkinson’s disease and related disorders, tremor, dystonia, myoclonus, and ataxia. She has particular expertise in using botulinum toxin injections to manage a range of neurological conditions, applying advanced techniques with a personalized, patient-centered approach. Dr. Kundrick completed both her neurology residency and movement disorders fellowship at Cleveland Clinic, where she developed a strong commitment to improving the quality of life for people living with complex neurological disorders. She is dedicated to patient and medical education, values collaborative decision-making, and works closely with each patient to create treatment plans tailored to their individual needs and goals.
Education & Training
Cleveland ClinicMovement Disorders Fellowship, 2023 - 2025
Cleveland Clinic FoundationResidency, Neurology, 2019 - 2023
Pennsylvania State University College of MedicineClass of 2019- Pennsylvania State UniversityB.S., Immunology and Infectious Disease, Schreyer's Honors College, 2011 - 2015
Certifications & Licensure
OH State Medical License 2021 - 2027
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 2 citationsPhosphorylated alpha-synuclein skin biopsy alters diagnosis in two out of three patients: Initial findings in a tertiary center.Saar Anis, Avery Kundrick, Camila Callegari Piccinin, Tatiana Lopez-Gonzalez, Daniel Teixeira-Dos-Santos
Parkinsonism & Related Disorders. 2026-04-01 - 1 citationsConvention vs. innovation I: Skin biopsy for synuclein inclusions should now be used in the clinical setting.Drew Kern, Avery Kundrick, Liana S Rosenthal
Parkinsonism & Related Disorders. 2025-07-01 - Convention vs. innovation III: The promise of stem cell therapy in Parkinson's disease remains bright.Alfonso Fasano, Avery Kundrick, Claire Henchcliffe
Parkinsonism & Related Disorders. 2025-07-01
Professional Memberships
- Member
- Movement Disorders SocietyMember
- International Association of Parkinsonism and Related DisordersMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
